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Abstract: The inhibition of axon regeneration upon mechanical injury is dependent on interactions
between Nogo receptors (NgRs) and their myelin-derived ligands. NgRs are composed of a
leucine-rich repeat (LRR) region, thought to be structurally similar among the different isoforms of
the receptor, and a divergent ‘‘stalk’’ region. It has been shown by others that the LRR and stalk
regions of NgR1 and NgR2 have distinct roles in conferring binding affinity to the myelin
associated glycoprotein (MAG) in vivo. Here, we show that purified recombinant full length NgR1
and NgR2 maintain significantly higher binding affinity for purified MAG as compared to the
isolated LRR region of either NgR1 or NgR2. We also present the crystal structure of the LRR and
part of the stalk regions of NgR2 and compare it to the previously reported NgR1 structure with
respect to the distinct signaling properties of the two receptor isoforms.
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Introduction
The ability of the adult central nervous system to
regenerate after injury is very limited due to the
formation of a glial scar1–4 and the presence of in-
hibitory molecules in the myelin debris.5–8 The
myelin-associated glycoprotein (MAG),9,10 Nogo-A
and the olygodendrocyte myelin glycoprotein (OMgp)
repress axon regeneration after mechanical damage.
These myelin-derived inhibitors share no amino acid
sequence or domain similarity; however, they bind to
the same neuronal receptor, which was initially
identified as a receptor for Nogo-A and termed
NgR.11 It was later confirmed that NgR binds MAG
and OMgp as well.12–15 As a glycosylphosphatidyli-
nositol (GPI)-anchored receptor, NgR lacks both the
transmembrane and the intracellular domains. A
number of possible signal transducing partners of
NgR have been identified, which include p75,16,17
LINGO,18 and TROY.19,20 The complex cascade of
reactions occurring upon receptor complex formation
culminates in changes in the neuronal cytoskeleton
that manifests in collapse of the neuronal growth
cone.
In addition to NgR1, two other isoforms of the
receptor, NgR2 and NgR3, were identified based on
amino acid sequence similarity and biochemical
homology.21–25 NgRs belong to the family of leucine-
rich repeat (LRR) proteins. Nogo receptors contain
eight LRRs flanked by the N- and C-terminal cyste-
ine-rich regions (LRRNT and LRRCT, respectively),
typical of this family of proteins.26 This N-terminal
region is highly conserved at the amino acid
sequence level among the NgRs. The LRR domain is
connected to the GPI-anchor for membrane attach-
ment via a C-terminal ‘‘stalk’’ region. The stalk
sequence is more divergent among the NgRs; there
are no defined structural motifs that can be pre-
dicted based on its amino acid composition. However,
the importance of this region has been clearly illus-
trated in studies of the receptor binding to MAG and
Nogo-66 in vivo.25,27 The stalk region could also be
involved in the interactions of the Nogo receptors
with co-receptors such as LINGO1 (unpublished ob-
servation). The crystal structure of the LRR domain
of human NgR1 has been determined previously.21,28
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Here, we report two structures of NgR2, one
includes the LRR domain only and the other the
LRR domain and part of the stalk region.
Results
We crystallized NgR2 (27-310), which contains the
LRR repeats and the flanking cysteine-rich domains
(LRRNT and LRRCT), and a slightly longer version,
NgR2 (27-330), which includes a part of the stalk do-
main. However, the region beyond residue 315 is dis-
ordered in the electron density map of NgR2-330
and was not modeled in the final structure. The
NgR2-310 and NgR2-330 crystals diffracted to 1.8 Å
and 2.1 Å, respectively, and the structure refinement
statistics are summarized in Table I. Our attempts
to obtain crystals of the full length NgR2 were
unsuccessful partly due to protein instability (fast
degradation). Human NgR1 and rat NgR2 share
50% amino acid sequence identity in the described
region (residues 27–330). Consequently, our NgR2-
310 structure is overall very similar to that of NgR1-
311 with the RMSD of 0.69 Å between 251 Ca atoms
[Fig. 1(A)]. The molecular architecture of the two
NgR2 constructs is that of a typical LRR with eight
repeating segments, each comprised of a short
b-strand and an extended loop. The arrangement of
b-strands and loops in LRR NgR2 is very similar to
that in NgR1 with the exception of a short a-helix
composed of residues Thr101-Arg103 present in
NgR2, but not in NgR1 [arrow 1 in Fig. 1(A)].
Similar to their NgR1 counterparts, the LRR
capping regions of NgR2 are stabilized by four disul-
fide bonds: Cys31-Cys37, Cys35-Cys46 at the N-ter-
minus and Cys265-Cys287, Cys267-Cys310 at the C-
terminus. Interestingly, there is also a free cysteine
buried inside the protein structure at the position
141. The LRRNT of NgR2 forms a loop between two
short b-strands (residues Thr36-Thr38 and Thr43-
Ser45). In contrast, this region in NgR1 does not
adopt a defined secondary structure and is one
amino acid longer than in NgR2 [arrow 2 in Fig.
1(A)]. The region comprising amino acids 104–243 is
structurally identical in the two proteins. The differ-
ences between NgR1 and NgR2 are localized to the
LRRCT capping region: there is a short a-helix
formed by Gly244-Asp249 in NgR2, but not in NgR1.
In addition, the a-helix that spans Asp297-Leu306
in NgR1 is split into two shorter helices (Leu299-
Thr301 and Asp304-Gln308) in NgR2, possibly pro-
viding a basis for more flexibility in the adjacent
stalk region.
Interestingly, the glycosylation pattern in NgR2
differs significantly from that of NgR1. In the previ-
ously reported structures of NgR121,28 the two glyco-
sylation sites are Asn82 and Asn179 [Fig. 1(C)],
whereas in our structure of NgR2 these asparagine
residues (structurally corresponding residues are
Asn83 and Asn180, of which only Asn180 has a
potential for sugar attachment) are not glycosylated.
Instead, Asn50, Asn93, and Asn236 are glycosylated
in NgR2 [Fig. 1(D)], while in NgR1 nonpolar
residues are found at these positions. Thus, in our
structure three out of four potential sites are glyco-
sylated. This important difference can contribute to
the distinct ligand binding preferences of NgR1
versus NgR2.
Similarly to NgR1, the LRR of NgR2 carries an
overall positive charge with a theoretical pI of 9. In
contrast, the stalk region at physiological pH has op-
posite charges in the two proteins: the calculated pI
of the stalk in NgR1 and NgR2 is 9 and 5, respec-
tively. Positive and negative charges on the surface
of NgR2 form several compact patches (Fig. 2). A
distinctive feature of this charge distribution is the
large S-shaped negatively charged area on the con-
vex surface, which extends into the beginning of the
Table I. Summary of Crystallographic Data
NgR2-310 NgR2-330
Space group P212121 P212121
Unit cell dimensions (Å) a ¼ 56.8, b ¼ 56.5, c ¼ 28.9 a ¼ 56.8, b ¼ 129.1, c ¼ 57
Resolution (Å)a 25.0 – 1.8 (1.9–1.8) 25.0 – 2.1 (2.2–2.1)
Completeness (%) 97.3 (76.9) 98.6 (89.5)
Number of reflections 38016 23662
Rmerge (%)
b 10.4 (41.2) 13.1 (44.2)
I/rI 18.3 (2.9) 19.4 (2.6)
Rfactor (%)
c 17.1 (28.6) 16.4 (22.6)
Rfree (%)
c 20.5 (37.3) 19.8 (30.6)
No. of nonhydrogen atoms 2684 2645
No. of waters 365 298
rmsd bonds (Å) 0.031 0.027
rmsd angles () 2.413 2.078
Each dataset was collected from a single crystal. Data statistics treats Bijvoët mates independently.
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stalk region (arrows 1 and 2 in Fig. 2). The corre-
sponding area is much smaller in NgR1 (bottom
panel in Fig. 2). Parallel to the acidic region is a
band of positively charged residues in NgR2, while
in NgR1 this area is mostly neutral. Two acidic
regions are found on the side of NgR2 (arrows 3 and
4) with positively charged residues localized to the
opposite side and the concave surface of the protein
(arrows 5 and 6).
To characterize the MAG interaction with the
NgR LRR domain as compared to that with the full-
length NgR1 and NgR2 proteins we used ELISA-
based in vitro binding assays. Our data clearly show
that the presence of the stalk region greatly enhan-
ces receptor binding to MAG (Fig. 3) for both NgR1
and NgR2, when using recombinant purified
proteins.
Discussion
Recent findings have alluded to the fact that the
LRR and stalk regions of the Nogo receptors have
distinct roles in the interactions of these receptors
with their ligand MAG. In particular, the NgR2
LRRCTþstalk region, alone or when fused to the
LRR of either NgR1 or NgR2, appears to signifi-
cantly enhance receptor binding to MAG in vivo.25,27
The exact role of the stalk region is not well under-
stood, however, partly due to the lack of structural
information. The purpose of this study was to deter-
mine the structure of NgR2 to further our under-
standing of the distinct ligand-binding affinities and
specificities of the different members of this receptor
family.
We crystallized two different NgR2 constructs:
NgR2 (27-310) and NgR2 (27-330) (Table I). The
crystal structures revealed that the overall architec-
ture of the LRR region of NgR2 is very similar to
that of NgR1. The major structural differences are
located at the C-terminus of the LRRCT region. The
distances between corresponding a-carbons in this
region progressively increase (2.9 Å for residue 304,
3.4 Å for residue 310, 8.3 Å for residue 311), imply-
ing that the adjacent stalk region of NgR2 is also
structurally different from that of NgR1. Our struc-
tures suggest that the two short a-helices in the be-
ginning of the stalk region of NgR2 (as opposed to
one longer helix in NgR1) may render the stalk
region more flexible than in NgR1, which would
affect ligand-induced structural rearrangements
and, consequently, binding affinity. We were unable
to obtain any structural data on most of the stalk
region as longer versions of NgR2 failed to crystal-
lize and this region was mostly disordered in our
NgR2 (27-330) crystals, confirming that the stalk is
disordered in the unbound form of the receptor. Low
degree of conservation in the amino acid composition
of the stalk region between the NgR homologs may
partly explain the difference in their binding affinity
to MAG. In addition, different charge distributions
within the LRRs of the NgRs may affect NgR-MAG
interactions indirectly. Specifically, the continuous
positively charged area on both the convex and con-
cave sides of NgR2 can contribute to binding of the
negatively-charged MAG (theoretical pI ¼ 4.8) under
physiological conditions.
The large surface area of the NgR isoforms pro-
vide an extensive platform for binding a diverse
group of ligands.21 Indeed, the different binding
partners of the Nogo receptors share neither amino
acid sequence similarity nor structural domain orga-
nization. Similar protein surface utilization for bind-
ing structurally very different ligands is illustrated
by the LRR-containing glycoprotein GpIba and its
complexes.29,30 Strikingly, our NgR2 (27-330) struc-
ture can be superimposed on the structure of glyco-
protein GpIba with the RMSD of 1.6 Å [Fig. 1(B)].
The major differences between the two structures
are localized to their C-terminal regions. The
LRRCT region of GpIba forms a b-switch on the
Figure 1. Structure of NgR2. (A) Comparison of the
structure of NgR1-311 (red) and NgR2-310 (green). Arrows
point to the differences between NgR1 and NgR2. (B)
Superposition of NgR2 (330) (green) and GpIba (red). (C)
Structure of NgR1 (311) with Asn-linked glycosylation
shown as bonds. (D) Structure of NgR2-330 with Asn-linked
glycosylation shown as bonds. Molecules in (C) and (D) are
in similar orientation.
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concave surface, a feature important for protein
function: it folds into a b-hairpin upon binding to
von Willebrand factor (VWF), stabilizing the contact
areas between the two proteins;29 NgR2 lacks this
structural feature. In addition, the extended LRRCT
of GpIba folds onto the convex side of the molecule
in the unliganded state, and moves away as part of
structural rearrangements occurring upon biding to
thrombin.30 Thus, the two proteins (VWF and
thrombin) bind to opposite sides of the GpIba mole-
cule. It is unclear whether the Nogo receptors bind
their various ligands in a structurally similar fash-
ion, and further studies are required to define the
exact roles of the different surface regions of the
Nogo receptors in binding their various ligands.
Finally, our structure clearly points to the major
difference between the two NgR isoforms – the gly-
cosylation patterns in the LRR region. Since this
profound difference in the molecular surface proper-
ties cannot be attributed to the different protein
expression systems used in NgR1 and NgR2 struc-
tural studies (here we used insect cells whereas both
insect and mammalian cells were used in the
reported NgR1 structures), we propose that the dif-
ferences in receptor glycosylation might be the main
reason for the different ligand binding and signaling
properties of NgR1 versus NgR2.
Materials and Methods
Protein expression and purification
DNA fragment encoding amino acids 27–310
(LRRNT þ LRR þ LRRCT) and 27–330 were ampli-
fied by PCR from the rat full-length NgR2 clone in a
pMT21 vector. Each fragment, including the N-ter-
minal signal sequence, and fused C-terminally to the
Fc region if human IgG, was cloned into the BamHI
and EcoRI sites of the pMA-152a baculovirus vector.
Figure 2. The molecular surface of NgR2 (330) (top) and NgR1 (311) (bottom) colored according to their electrostatic
potential. Convex (left) and concave (right) surfaces are shown. Red indicates negative charge and blue indicates positive
charge.
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The vector was then transfected into Sf9 cells. Pas-
sage 3 recombinant virus was used for Hi5 cells
infection in SF-900 II serum-free medium. The cells
were grown in suspension at 27C and 100 rpm. The
protein was purified from expression medium using
protein-A sepharose chromatography followed by re-
moval of the Fc tag by thrombin and gel-filtration
chromatography. The apparent molecular mass of
each protein was 40 kDa, higher than the calcu-
lated mass of 32 kDa due to glycosylation. NgR2
(27-310) and NgR2 (27-330) were purified to >95%
purity as indicated by SDS-PAGE.
Crystallization and structure determination
Purified protein was concentrated to 10 mg/mL in
10 mM HEPES (pH 7.2) and 500 mM KCl and crys-
tallized at 20C in a hanging drop containing equal
volumes of protein and well solution. The well solu-
tion for NgR2 (310) contained 100 mM HEPES-Na
(pH 7.5), 10% isopropanol, and 15% polyethylene
glycol 10,000, for NgR2 (330)–or 0.6M K/NaPO4, pH
7.6. For structure determination single-wavelength
data sets were collected at Advanced Photon Source
beamline ID-24. The structures were determined by
molecular replacement with NgR1 (26-311) as a
model (see Table I).
Binding assays
Wells of a 96-well microtiter plate (Nunc) were
coated overnight at 4C with 2 lg of purified MAG in
0.1 mL of buffer (10 mM HEPES, 150 mM KCl,
0.05% Tween 20 at pH 7.4). Unbound protein was
decanted and the wells washed thrice with the same
buffer. They were then filed with 0.2 mL of 2% non-
fat milk (Bio-Rad) and incubated at 25C for 1 hour.
The wells were washed again and incubated in quad-
ruplicate with 1 lg of either NgR1 (26-311)-Fc, NgR1
(26-460)-Fc, NgR2 (27-330)-Fc, or NgR2 (27-420)-Fc
for 1 hour at 25C. Purified Fc fragment was used as
a control. After washing, the wells were incubated
for 1 hour with 0.1 mL of affinity-pure goat anti-
human IgG, Fc fragment specific antibody (Jackson
immuno research laboratory) at a dilution of 1:200.
After washing, the wells were incubated with donkey
anti-goat IgG conjugated to horseradish peroxidase
(Promega) at a dilution of 1:2000 for 1 hour. Finally,
color was developed using the immunopure TMB
substrate kit (Thermoscientific) and OD at 450 nm
was recorded on a 96-well plate reader Victor X5
(Perkin Elmer). Data points were corrected for the
binding of the isolated Fc fragment to MAG and
normalized with respect to full-length NgR1.
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